Webinar: Canine CRP - Inflammation marker in plasma and serum

13. Aug 2020 | 3 min read

Webinar: Canine CRP - Inflammation marker in plasma and serum

Canine CRP Immunoassay

Gentian Canine CRP Immunoassay is an in vitro diagnostic test for quantitative determination of canine C-reactive protein (CRP) in dog serum and plasma, which has an important role in diagnosis and monitoring of inflammatory disorders in dogs.

Want to know more about Gentian’s Canine CRP immunoassay?

The Product Manager for Canine CRP, Dr. Paula Lindner will go more into details about both CRP in dogs in general and the advantages of Gentian's immunoassay in the webinar below:

Details about the biomarker CRP in general

  • Canine CRP in the inflammation response
  • Canine CRP as reliable biomarker for diagnosis and monitoring of systemic inflammation

 

More insights to Gentian Canine CRP immunoassay advantages

  • A Particle-Enhanced Turbidimetric Immunoassay (PETIA) for in vitro diagnostic testing of canine CRP in dog plasma and serum sample
  • Canine-specific avian antibodies for high specificity and sensitivity
  • Fast and easy assay procedure
  • Available for a wide range of clinical analysers

Watch the webinar

 


Contact us

Please send an email to marketing@gentian.com or fill out the form below to get in touch with Product Manager Dr. Paula Lindner.

 

Canine CRP inflammation marker in plasma and serum

You may also read


Cystatin C testing - Balancing additional costs against potential benefits

Apr 11, 2024

Cystatin C testing - Balancing additional costs against potential benefits

The KDIGO (Kidney Disease: Improving Global Outcomes) 2024 Clinical Practice Guideline for the Evaluation and..

Scientists to Gentian’s R&D department

Apr 08, 2024

Scientists to Gentian’s R&D department

Scientists to Gentian’s application validation group We are looking for two new colleagues in the positions..

KDIGO CKD 2024 guidelines: Patients benefiting from combined cystatin C and creatinine

Apr 03, 2024

KDIGO CKD 2024 guidelines: Patients benefiting from combined cystatin C and creatinine

The global non-profit organisation KDIGO (Kidney Disease: Improving Global Outcomes), commits to create and..